Inhibikase Therapeutics

Inhibikase Therapeutics Inhibikase (Nasdaq: IKT) is a clinical-stage pharma company developing protein kinase inhibitors

Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.

Address

3350 Riverwood Parkway, Suite 1900
Atlanta, GA
30339

Telephone

+16783923419

Website

Alerts

Be the first to know and let us send you an email when Inhibikase Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category